Mindray Introduces Enhancements for M Series Ultrasound Platforms at ASA

MAHWAH, N. J., October 14, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will be showcasing its newly enhanced hand-held M series ultrasound platforms at the American Society of Anesthesiologists (ASA) conference being held in Chicago between October 14-18, 2011.

The M7 Ultrasound Platform Enhancements

The M7 platform provides a wealth of advanced imaging features including excellent temporal resolution and innovative multiple-tissue harmonic imaging technologies to improve image quality for technically difficult patients. During the ASA conference, Mindray will be launching the new needle visualization technology, iNeedle, which provides physicians with clear and precise needle detection during procedures. The iNeedle, in conjunction with iZoom, enables users to view patient anatomy more accurately from a distance while iTouch allows for optimized image with a single button. These features help physicians see target structures more clearly and easily for safe and effective anesthetic procedures.

Mindray will also introduce new transducers including the linear array L12-4s and L14-6Ns. The latter are particularly noteworthy because they provide high frequency imaging for nerve and pain management as well as other applications.

"The M7 ultrasound platform has been incredibly well received since the first shipment to North American customers in last June," said Michael Thompson, Vice President of Ultrasound Sales, Mindray North America. "The M7 system elevates hand-carried units (HCU) performance standards to a new level. Due to the highly upgradable system architecture of both the M5 and the M7, we are able to support existing as well as new customers with significant system enhancements and new features introductions."

The M5 Ultrasound Platform Enhancements

The company will highlight its popular M5 ultrasound platform, which represents significant value and high performance in a hand-carried device for general ultrasound imaging services. Mindray has released enhancements, such as new transducers, image improvements and other applications, over the past several months.

"Our focus on turning customer insights into meaningful innovations continues with the latest enhancements to the M Series ultrasound platform," said David Gibson, President of Mindray North America. "We continue to push the frontier of the performance-to-price ratio in order to give clinicians more capabilities in a budget-constrained environment."

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.